Clinical Trial Update: A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A randomized Phase II/Genomic trial comparing two chemotherapy regimens in patients with resected pancreatic adenocarcinoma has completed and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-02-25